Combination therapy shows promise for hereditary papillary kidney cancer
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC)-associated papillary RCC is [...]
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC)-associated papillary RCC is [...]
Results from a phase II study of bevacizumab and erlotinib [...]
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a hereditary condition associated [...]
This interview with Dr Ramaprasad Srinivasan from the National Cancer Institute in [...]
In this video, Dr W. Marston Linehan, chief of the [...]